AR041546A1 - Agentes antibacterianos de tetrahidroquiolina triciclicos - Google Patents
Agentes antibacterianos de tetrahidroquiolina triciclicosInfo
- Publication number
- AR041546A1 AR041546A1 ARP030103650A ARP030103650A AR041546A1 AR 041546 A1 AR041546 A1 AR 041546A1 AR P030103650 A ARP030103650 A AR P030103650A AR P030103650 A ARP030103650 A AR P030103650A AR 041546 A1 AR041546 A1 AR 041546A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- alkyl
- halo
- partially unsaturated
- substituents
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 33
- 125000005843 halogen group Chemical group 0.000 abstract 17
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 13
- 125000001072 heteroaryl group Chemical group 0.000 abstract 13
- 125000003118 aryl group Chemical group 0.000 abstract 12
- 125000001424 substituent group Chemical group 0.000 abstract 11
- 125000003545 alkoxy group Chemical group 0.000 abstract 10
- 101100212791 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YBL068W-A gene Proteins 0.000 abstract 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 3
- 125000002950 monocyclic group Chemical group 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 125000006413 ring segment Chemical group 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 239000011593 sulfur Substances 0.000 abstract 3
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 125000002619 bicyclic group Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- -1 -OH Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical group O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 abstract 1
- LOGSONSNCYTHPS-UHFFFAOYSA-N cyclopentane-1,3-dione Chemical group O=C1CCC(=O)C1 LOGSONSNCYTHPS-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41668502P | 2002-10-07 | 2002-10-07 | |
| US42718902P | 2002-11-18 | 2002-11-18 | |
| US45762203P | 2003-03-26 | 2003-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041546A1 true AR041546A1 (es) | 2005-05-18 |
Family
ID=32074379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030103650A AR041546A1 (es) | 2002-10-07 | 2003-10-07 | Agentes antibacterianos de tetrahidroquiolina triciclicos |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US7208490B2 (enExample) |
| EP (1) | EP1551849B1 (enExample) |
| JP (1) | JP4009652B2 (enExample) |
| AR (1) | AR041546A1 (enExample) |
| AT (1) | ATE473985T1 (enExample) |
| AU (1) | AU2003264768A1 (enExample) |
| BR (1) | BR0315139A (enExample) |
| CA (1) | CA2500824C (enExample) |
| CY (1) | CY1110821T1 (enExample) |
| DE (1) | DE60333379D1 (enExample) |
| DK (1) | DK1551849T3 (enExample) |
| MX (1) | MXPA05002701A (enExample) |
| PT (1) | PT1551849E (enExample) |
| SI (1) | SI1551849T1 (enExample) |
| TW (1) | TWI295671B (enExample) |
| WO (1) | WO2004031195A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| JP2008543739A (ja) * | 2005-05-09 | 2008-12-04 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 抗菌剤 |
| DOP2006000268A (es) * | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| CN101784553A (zh) * | 2007-07-02 | 2010-07-21 | 阿斯利康(瑞典)有限公司 | 3-螺嘧啶三酮-喹啉衍生物及其作为抗菌药物的应用 |
| RU2010105007A (ru) | 2007-07-16 | 2011-08-27 | Астразенека Аб (Se) | Химические соединения |
| AU2009305203B2 (en) * | 2008-10-14 | 2013-03-07 | Entasis Therapeutics Limited | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| WO2010075380A1 (en) * | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
| BR112013001138A2 (pt) | 2010-07-16 | 2016-07-05 | Abbvie Inc | ligantes de fosfina para reações catalíticas |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| WO2012009699A2 (en) | 2010-07-16 | 2012-01-19 | Abbott Laboratories | Process for preparing antiviral compounds |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| RU2644250C2 (ru) * | 2012-09-14 | 2018-02-08 | Элизабет ЛЕВИНА | Лекарственное средство с активностью против грамположительных бактерий, микобактерий и грибов |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| JP6156845B2 (ja) * | 2014-03-04 | 2017-07-05 | 株式会社島津製作所 | マトリックス支援レーザ脱離イオン化質量分析用マトリックス |
| EA033459B1 (ru) | 2014-05-29 | 2019-10-31 | Entasis Therapeutics Ltd | Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекций |
| WO2017156519A1 (en) | 2016-03-11 | 2017-09-14 | The Board Of Trustees Of The University Of Illinois | Small-molecules active against gram-negative bacteria |
| US11274106B2 (en) | 2017-06-23 | 2022-03-15 | The Board Of Trustees Of The University Of Illinois | Topoisomerase inhibitors with antibacterial and anticancer activity |
| CN108101860B (zh) * | 2018-02-08 | 2021-11-23 | 苏州敬业医药化工有限公司 | 顺式-2，6-二甲基吗啉的制备方法 |
| CN115466212B (zh) * | 2022-10-26 | 2023-09-22 | 河南农业大学 | 一种2-三氟甲基喹啉类化合物及其合成方法和应用 |
| CN118878546B (zh) * | 2024-09-30 | 2025-01-03 | 苏州大学 | 一种螺环巴比妥酸衍生物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011860A (en) | 1986-04-11 | 1991-04-30 | Schering Corporation | Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases |
| DE19502178A1 (de) | 1994-01-27 | 1995-08-03 | Hoechst Ag | Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen |
| CA2425283A1 (en) | 2000-10-26 | 2002-05-02 | Pfizer Products Inc. | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| WO2003091252A1 (en) | 2002-04-25 | 2003-11-06 | Bristol-Myers Squibb Company | Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| MXPA05003774A (es) | 2002-10-10 | 2005-06-08 | Pharmacia & Upjohn Co Llc | Compuestos de 1-aril-dihidropiridona con actividad antimicrobiana. |
-
2003
- 2003-10-02 US US10/677,551 patent/US7208490B2/en not_active Expired - Fee Related
- 2003-10-03 MX MXPA05002701A patent/MXPA05002701A/es active IP Right Grant
- 2003-10-03 CA CA2500824A patent/CA2500824C/en not_active Expired - Fee Related
- 2003-10-03 DE DE60333379T patent/DE60333379D1/de not_active Expired - Lifetime
- 2003-10-03 PT PT03799056T patent/PT1551849E/pt unknown
- 2003-10-03 DK DK03799056.1T patent/DK1551849T3/da active
- 2003-10-03 BR BR0315139-5A patent/BR0315139A/pt not_active IP Right Cessation
- 2003-10-03 WO PCT/IB2003/004389 patent/WO2004031195A1/en not_active Ceased
- 2003-10-03 JP JP2005500077A patent/JP4009652B2/ja not_active Expired - Fee Related
- 2003-10-03 AT AT03799056T patent/ATE473985T1/de active
- 2003-10-03 AU AU2003264768A patent/AU2003264768A1/en not_active Abandoned
- 2003-10-03 EP EP03799056A patent/EP1551849B1/en not_active Expired - Lifetime
- 2003-10-03 SI SI200331869T patent/SI1551849T1/sl unknown
- 2003-10-06 TW TW092127679A patent/TWI295671B/zh not_active IP Right Cessation
- 2003-10-07 AR ARP030103650A patent/AR041546A1/es not_active Application Discontinuation
-
2007
- 2007-03-07 US US11/715,213 patent/US7605157B2/en not_active Expired - Fee Related
-
2009
- 2009-08-28 US US12/549,407 patent/US20100022524A1/en not_active Abandoned
-
2010
- 2010-10-06 CY CY20101100894T patent/CY1110821T1/el unknown
- 2010-12-20 US US12/972,921 patent/US8420646B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7605157B2 (en) | 2009-10-20 |
| JP4009652B2 (ja) | 2007-11-21 |
| US7208490B2 (en) | 2007-04-24 |
| SI1551849T1 (sl) | 2010-11-30 |
| DK1551849T3 (da) | 2010-10-25 |
| ATE473985T1 (de) | 2010-07-15 |
| CA2500824C (en) | 2011-03-22 |
| US20070161630A1 (en) | 2007-07-12 |
| EP1551849A1 (en) | 2005-07-13 |
| EP1551849B1 (en) | 2010-07-14 |
| US20110092494A1 (en) | 2011-04-21 |
| CA2500824A1 (en) | 2004-04-15 |
| TWI295671B (en) | 2008-04-11 |
| BR0315139A (pt) | 2005-08-09 |
| WO2004031195A1 (en) | 2004-04-15 |
| PT1551849E (pt) | 2010-09-27 |
| US20040162279A1 (en) | 2004-08-19 |
| AU2003264768A1 (en) | 2004-04-23 |
| JP2006511595A (ja) | 2006-04-06 |
| US20100022524A1 (en) | 2010-01-28 |
| DE60333379D1 (de) | 2010-08-26 |
| CY1110821T1 (el) | 2015-06-10 |
| TW200413394A (en) | 2004-08-01 |
| US8420646B2 (en) | 2013-04-16 |
| MXPA05002701A (es) | 2005-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20021010A1 (es) | Derivados espirociclicos como inhibidores de fosfodiesterasa-7 | |
| AR017014A1 (es) | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos | |
| PA8547901A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| AR075005A1 (es) | Derivados de sulfonamida | |
| AR057071A1 (es) | Producto de combinacion que comprende arilpirazoles sustituidos | |
| AR044005A1 (es) | Compuestos biciclicos, procedimiento para su preparacion, su uso para preparar un medicamento y composiciones farmaceuticas que los comprenden | |
| AR053652A1 (es) | Derivados de indol como inhibidores de proteina quinasas. composiciones farmaceuticas | |
| AR054809A1 (es) | Compuestos de amino -5-heteroarilo (5 miembros) imidazolona y su uso para la modulacion de la b- secretasa | |
| AR020165A1 (es) | Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos | |
| AR047823A1 (es) | Derivados de 1,2,3,4-tetrahidroisoquinolina sustituida | |
| UY27322A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
| AR046711A1 (es) | 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones | |
| AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
| AR045955A1 (es) | Compuestos benzoimidazolicos | |
| AR062499A1 (es) | Derivados de n-fenil pirazol y piridil pirazoles, composiciones farmaceuticas que los contienen y usos como agentes antiagregantes plaquetarios y antitromboticos. | |
| AR044402A1 (es) | Compuestos heterociclicos y su uso como inmunodepresores. composiciones farmaceuticas que los contienen. | |
| AR013076A1 (es) | Nuevos compuestos de piperazina, un procedimiento para su preparacion y una composicion farmaceutica que los comprende | |
| AR059184A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica | |
| AR061369A1 (es) | Derivados de pirimidina y composiciones farmaceuticas que los comprenden | |
| AR037907A1 (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
| AR045255A1 (es) | Derivados de 1,2 benzodiazol | |
| NI200800015A (es) | Derivados de n-(heteroaril)-1-heteroarilalquil - 1h - indol - 2 - carboxamidas, su preparación y su aplicación en terapéutica. | |
| ES2169248T3 (es) | Compuestos aromaticos y composiciones farmaceuticas que los contienen. | |
| AR067954A1 (es) | Compuestos de carbazol | |
| CA2500824A1 (en) | Tricyclic tetrahydroquinoline antibacterial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |